The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …
"health"
-
-
A recent study has found that around 35% of tattoo and permanent makeup inks sold in the United States are contaminated with bacteria. This discovery raises significant concerns about the …
-
A major federal initiative aimed at reducing opioid overdose deaths by 40% has not met its goal, the National Institutes of Health (NIH) has announced. Launched in 2019, the HEALing …
-
The FDA has announced a nationwide recall of potassium chloride extended-release capsules due to a risk of heart attacks from improper dissolution. Glenmark Pharmaceuticals and American Health Packaging are recalling …
-
House Republican leaders have initiated calls for a rigorous investigation into suspected widespread fraud within the Affordable Care Act (ACA) enrollment system. This demand follows a report by the Paragon …
-
The House Ways and Means Committee advanced four bills on Thursday, aiming to allow Medicare to cover weight-loss drugs for certain beneficiaries. The vote, which passed 36-4, is a crucial …
-
In 2022, California’s economy suffered a significant impact from obesity-related health issues, with an estimated $90 billion loss in economic activity. This led to an $11 billion deficit in the …
-
Recent research has revealed a significant rise in Type 1 diabetes among older adults, with cases tripling over the past 30 years. The number of affected seniors aged 65 and …
-
U.S. job openings have dropped to their lowest level since February 2021, indicating a cooling job market. As of April, job vacancies decreased to 8.1 million, down from 8.4 million …
-
U.S. health authorities are warning the medical community and the public of a sharp increase in dengue fever cases around the world. This rise is being fueled by climate change …